Notable Guests
DG
Derrick Gingery
8x
SS
Sue Sutter
8x
NH
Nielsen Hobbs
8x
BB
Brian Bossetta
7x
EO
Elizabeth Orr
7x
CR
Claire Riches
6x
NB
Natasha Barrow
6x
XH
Xu Hu
6x
DW
Dave Wallace
5x
MW
Marion Webb
5x
SS
Shubham Singh
5x
JH
Joseph Haas
4x
MO
Maaisha Osman
4x
EW
Emma Wille
4x
BY
Brian Yang
4x
Recent Episodes
✨
China's competitive threat and Q3 M&A slowdown discussed.
✨
Celebrity marketing viability under FDA scrutiny examined.
Frank Watanabe
✨
FDA faces drama over HHS plan to allow temporary compounding of unapproved peptides.
Bridget Silverman
Derrick Gingery
Maaisha Osman
Sue Sutter
✨
Julia Pike discusses the European IP system and its comparison to the US.
Julia Pike
Strategic Intent: Using Agentic AI To Create ‘The Self-Driving Clinical Trial, Kind Of Like The Car’
✨
Ken Getz and Pamela Tanaerts discuss AI in clinical trials.
Ken Getz
Pamela Tanaerts
✨
Global Self-Care Federation updates value analysis.
Ben Carrick
Greg Perry
✨
Limited impact of CMS GLOBE model discussed.
✨
Seek Labs CEO discusses AI for diagnostics and therapeutics.
✨
China's five-year plan boosts biopharma growth.
✨
Boehringer Ingelheim's US launch strategy covers ILD, cardiometabolic, and obesity markets.
Brian Hilberdink
✨
Analysis of Heidi Overton's FDA commissioner confirmation hearing responses.
✨
Episode: Advancing CNS Drug Development Through AI, New Approach Methodologies and Regulatory Innovation
✨
Psychedelic medicine dealmaking environment influenced by recent acquisitions.
Emma Wille
Joseph Haas
✨
Rubedo Life Sciences focuses on turning aging biology into medicines.
Frederick Beddingfield
✨
Oura Ring plans IPO amidst new partnerships and a lawsuit.
Brian Bossetta
George Underwood
Marion Webb
Shubham Singh
✨
Nouscom develops personalized and off-the-shelf cancer vaccines.
✨
Scaling self-care in Asia Pacific, focusing on Indonesia.
Anama O'Reilly
Rachmadi Joesoef
✨
Impact of permanent CDER and CBER directors on FDA leadership.
✨
Evolving requirements and trends in life sciences leadership.
✨
Review of Heidi Overton's financial and educational background for FDA role.